Anastasios Gianakakos

Affiliations

  • Director at Lianbio (LIAN), 2024-02-20
  • President And Ceo at Myokardia Inc. (MYOK), 2020-11-20
  • Svp, Chief Business Officer at Map Pharmaceuticals Inc. (MAPP), 2013-03-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MYOK $39.87 1,600 $63,795.52 88,473 2019-01-04 Filing
MYOK $39.84 900 $35,851.50 86,873 2019-01-04 Filing
MYOK $8.50 2,279 $19,371.50 484,444 2016-04-29 Filing
MYOK $10.00 1,350 $13,500.00 482,165 2015-11-03 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MYOK $94.22 3,224 $303,766.89 19,122 2020-07-02 Filing
MYOK $93.55 1,776 $166,142.14 22,346 2020-07-02 Filing
MYOK $104.64 319 $33,381.63 24,122 2020-06-02 Filing
MYOK $103.77 1,885 $195,609.47 24,441 2020-06-02 Filing
MYOK $102.78 1,396 $143,481.44 26,326 2020-06-02 Filing